Review: clinical management of Helicobacter pylori infection in China.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Helicobacter pylori Antibody Titer and Gastric Cancer ScreeningPrimary Antibiotic Resistance of Helicobacter pylori in China.Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study.The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial.Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-AnalysisDietary Patterns are Associated with Helicobacter Pylori Infection in Chinese Adults: A Cross-Sectional Study.Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple TherapyImpact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data.Cost-effectiveness analysis of oral versus intravenous drip infusion of levofloxacin in the treatment of acute lower respiratory tract infection in Chinese elderly patients.Kyoto global consensus report on Helicobacter pylori gastritis and its impact on Chinese clinical practice.Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population.Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China.Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication.
P2860
Q26777623-CDBD6BA0-2F59-4630-AB04-37D0604C6BD1Q26780322-6E653867-BC41-448D-A399-BD3BF67BAD92Q30235219-BC2A587C-575C-487B-9366-55E61FAC553EQ33425621-17C8565C-DB76-4FF8-81E2-E5EB9B1B54D8Q35794384-22B0387C-322B-40D5-B24C-99F4A71B2953Q35914868-F43C6F67-F3F1-47AC-8E09-81DFB11E58B7Q37206124-5B5ADED9-1D2E-4991-A8CE-6CCDF28B3A09Q37215735-551EBFE2-9D4D-462E-A9EE-08385B385544Q37328573-6B69D3EF-44B3-4271-98BE-1214651AEAB1Q38649076-59DA63D5-E7D0-459C-9CA4-5F94B7D193A8Q40237758-E6FD56AF-F962-405B-8CB2-7E2BAFD5B419Q40680535-31EF3AE0-D690-4F7B-B564-DB07C93D9FB6Q41109290-0C886C5B-76F6-4D9B-8D4A-1C9C553D72EAQ41867496-560B2827-C25B-49C2-825F-413E56BEF725Q47222389-644D0772-E24A-4BA7-B08E-F1B85FE712C5
P2860
Review: clinical management of Helicobacter pylori infection in China.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Review: clinical management of Helicobacter pylori infection in China.
@en
type
label
Review: clinical management of Helicobacter pylori infection in China.
@en
prefLabel
Review: clinical management of Helicobacter pylori infection in China.
@en
P2860
P356
P1433
P1476
Review: clinical management of Helicobacter pylori infection in China.
@en
P2093
Nong-Hua Lu
P2860
P356
10.1111/HEL.12178
P577
2014-11-08T00:00:00Z